Pulmonary embolism resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 165: Line 165:


In hospitals that have experience in performing and interpreting CT pulmonary angiography, the following flowchart approach can be adopted.
In hospitals that have experience in performing and interpreting CT pulmonary angiography, the following flowchart approach can be adopted.
{{familytree/start |summary=PE diagnosis Algorithm.}}
{{familytree | | | | | | | | GMa | GMa='''Determine chances of PE'''}}
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }}
{{familytree | | |JOE| | | | | | | |SIS| | | JOE='''Low chance'''|SIS='''High chance'''}}
{{familytree | | | |!| | | | | | | | | |!| }}
{{familytree | | |MOM| | | | | | | | |!| |MOM='''[[D-dimer]]'''}}
{{familytree | |,|-|^|.| | | | | | | | |!| }}
{{familytree |GPa| |JOE|~|~|~|~|~|MOM|GPa='''<500 ng/ml'''|JOE='''>500 ng/ml'''|MOM='''[[Pulmonary embolism other imaging findings#Angiography|CT Pulmonary angiography]]'''}}
{{familytree | |!| | | | | | | | | |,|-|^|.| }}
{{familytree |MOM| | | | | | |SIS| | |GMa|MOM='''PE excluded'''|SIS=Negative|GMa=Positive}}
{{familytree | | | | | | | | | | |!| | | | |!| }}
{{familytree | | | | | | | | | |SIS| | |GMa|SIS='''PE excluded'''|GMa='''PE confirmed'''}}
{{familytree/end}}


'''Note:''' ''If there is a high clinical suspicion of pulmonary embolism, then anticoagulation can begin with a parenteral agent such as unfractionated heparin during the process of performing the diagnostic studies.''
'''Note:''' ''If there is a high clinical suspicion of pulmonary embolism, then anticoagulation can begin with a parenteral agent such as unfractionated heparin during the process of performing the diagnostic studies.''

Revision as of 01:42, 25 April 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Rim Halaby; Pratik Bahekar, MBBS [2]; Chetan Lokhande, M.B.B.S [3]

Pulmonary embolism Resident Survival Guide Microchapters
Overview
Causes
FIRE
Diagnosis
Treatment
Do's
Don'ts

Overview

Pulmonary embolism (PE) is an acute obstruction of the pulmonary artery (or one of its branches). The obstruction in the pulmonary artery can be due to thrombus, air, tumor, or fat. Most often, this is due to a venous thrombosis (blood clot from a vein), which has been dislodged from its site of formation in the lower extremities. It has then embolized to the arterial blood supply of one of the lungs. This process is termed thromboembolism. PE is a potentially lethal condition. The patient can present with a range of signs and symptoms, including dyspnea, chest pain while breathing, and in more severe cases collapse, shock, and cardiac arrest. Pulmonary embolism can be classified based on the time course of symptom presentation (acute and chronic) and the overall severity of disease (stratified based upon three levels of risk: massive, submassive, and low-risk). PE treatment requires rapid and accurate risk stratification before the development of hemodynamic collapse and cardiogenic shock. Treatment consists of an anticoagulant medication, such as heparin or warfarin, and in severe cases, thrombolysis or surgery.

Causes

Life Threatening Causes

Life-threatening causes include conditions which result in death or permanent disability within 24 hours if left untreated.

Common Causes

Classification

Pulmonary embolism can be classified based on the time course of symptom presentation (acute and chronic) and the overall severity of disease (stratified based upon three levels of risk: massive, submassive, and low-risk).

Massive Pulmonary Embolism

Submassive Pulmonary Embolism

An acute PE without systemic hypotension (systolic blood pressure >90 mm Hg) but with either, right ventricular dysfunction or myocardial necrosis.

  1. Right ventricular dysfunction: It is defined by the presence of at least one of the following features,
    • Echocardiography findings:
      1. RV dilation (apical 4-chamber RV diameter divided by LV diameter > 0.9)
      2. RV systolic dysfunction
    • CT findings: RV dilation (4-chamber RV diameter divided by LV diameter > 0.9)
    • BNP > 90 pg/mL
    • N-terminal pro-BNP >500 pg/mL
    • EKG findings:
      1. New complete or incomplete right bundle-branch block
      2. Anteroseptal ST elevation or depression
      3. Anteroseptal T-wave inversion.
  2. Myocardial necrosis: It is defined as the presence of either one of the following:

Low-Risk Pulmonary Embolism

An acute pulmonary embolism without the life threatening clinical markers that define massive or submassive pulmonary emboli. [1]

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.
Boxes in salmon color signify that an urgent management is needed.

Abbreviations: AVR: Aortic valve replacement; CK-MB: Creatine kinase myocardial type; ECG: Electrocardiogram; NSTEMI: Non ST elevation myocardial infarction; STEMI: ST elevation myocardial infarction; TTE: Transthoracic echocardiography

 
 
 
 
 
 
Identify cardinal findings that increase the pretest probability of pulmonary embolism

❑ Dyspnea at rest or with exertion
Pleuritic pain
Cough
Tachycardia
❑ Accentuated P2
Wheezing
Tachypnea
Syncope
❑ Decreased breath sounds
❑ Calf or thigh pain and swelling
❑ Edema, erythema, tenderness, or a palpable cord in the calf or thigh

❑ Recurrent miscarriage in a previously pregnant female
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any of the following findings of massive pulmonary embolism that require urgent management?

>2- Pillow orthopnea
Hypotension
Jugular venous distension
Right-sided S3
Parasternal lift
❑ EKG demonstrates,

❑ Atrial arrhythmias
❑ Right bundle branch block
❑ Inferior Q-waves
❑ Precordial T-wave inversion and ST-segment changes

❑ ABG shows,

❑ Hypercapnia
❑ Combined respiratory and metabolic acidosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Perform D-dimer
❑ Erythrocyte agglutination assay (takes upto 2 min)
❑ Semi-quantitative latex agglutination assay (takes upto 5 min)
❑ Semi-quantitative rapid ELISA (takes upto 10 min)
❑ Qualitative rapid ELISA (takes upto 10 min)
❑ Quantitative latex agglutination assay (takes upto 15 min)
❑ Quantitative rapid ELISA (takes upto 30 min)

❑ V/Q scan

 
 
 
 
Proceed to the
complete diagnostic approach below
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

❑ High clinical probability with high-probability V/Q scan has 95% chance of having PE
 
PE can not be excluded

❑ D-dimer level >500 ng/mL
 
PE excluded

❑ Normal V/Q scan

❑ Low clinical probability with low-probability V/Q scan has 4% chance of having PE
❑ D-dimer level <500 ng/mL excludes the diagnosis in low pretest probability

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proceed with the management
 
Perform CT Pulmonary angiography to confirm the diagnosis of PE
 
Proceed to the
complete diagnostic approach below
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess for presence of anticoagulation contraindication

❑ Major bleeding diathesis (e.g. coagulation defects, platelet count < 40,000)
ƒ❑ Uncontrollable active bleeding state
❑ƒ Acute haemorrhagic stroke
ƒ❑ Cerebral lesions at high risk of bleeding
❑ƒ Active ulcerative or angiodysplastic gastrointestinal disease
ƒ❑ Proliferative diabetic retinopathy
ƒ❑ Severe uncontrolled hypertension

ƒ❑ Severe renal and/or hepatic dysfunction
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IVC filter
 
Start Anticoagulation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Submassive PE
 
Massive PE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess clinically for evidence of increased severity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evidence of shock (SBP <90 mmHg) or respiratory failure
 
Is thrombolytic contraindicated?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical emblectomy or catheter based interventions
 
Hold anticoagulation, give thrombolytics then resume anticoagulations
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient shows clinical improvement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical emblectomy or catheter based interventions
 
Continue anticoagulation

Complete Diagnostic Approach

A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.

Step 1: Establish The Diagnosis Of Pulmonary Embolism

In hospitals that have experience in performing and interpreting CT pulmonary angiography, the following flowchart approach can be adopted.

Note: If there is a high clinical suspicion of pulmonary embolism, then anticoagulation can begin with a parenteral agent such as unfractionated heparin during the process of performing the diagnostic studies.

Treatment

Step 2: Use A Risk-Stratified Approach to Treat the Patient with Pulmonary Embolism

 
 
 
 
 
 
 
 
Confirmed PE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess Clinical
Stability
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unstable
 
 
 
 
 
 
 
 
 
 
 
Stable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blood pressure ≦ 90mm
Drop in BP ≧ 40mm for > 15 min
 
 
 
 
 
 
 
 
 
 
 
Assess RV function
Biomarkers of injury
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thrombolysis
Catheter embolectomy
Surgery
 
 
 
 
 
 
 
No Dysfunction
+
No injury
 
Dysfunction
+
No injury
 
 
Dysfunction
+
Injury
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anticoagulation
Early discharge
 
Anticoagulation
Ward admission
 
 
Thrombolytics
ICU admission

Step 3: Assess Treatment Response and Need for Device Based Therapy

 
 
 
 
 
 
 
Acute PE confirmed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anticoagulation contraindicated ?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IVC filter
 
 
 
 
 
 
 
Risk stratification
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low-risk PE
 
 
 
Submassive PE
 
Massive PE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anticoagulation
 
 
 
Anticoagulation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess clinically for evidence of increased severity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evidence of shock (SBP <90 mmHg) or respiratory failure
 
Is thrombolytic contraindicated?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical emblectomy or catheter based interventions
 
Hold anticoagulation, give thrombolytics then resume anticoagulations
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient shows clinical improvement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical emblectomy or catheter based interventions
 
Continue anticoagulation

Do's

Don'ts

References

  1. 1.0 1.1 1.2 Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ; et al. (2011). "Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association". Circulation. 123 (16): 1788–830. doi:10.1161/CIR.0b013e318214914f. PMID 21422387.
  2. Cannon CP, Goldhaber SZ (1996). "Cardiovascular risk stratification of pulmonary embolism". Am. J. Cardiol. 78 (10): 1149–51. PMID 8914880. Retrieved 2011-12-21. Unknown parameter |month= ignored (help)